vs

Side-by-side financial comparison of Booz Allen Hamilton Holding Corp (BAH) and CME Group (CME). Click either name above to swap in a different company.

Booz Allen Hamilton Holding Corp is the larger business by last-quarter revenue ($2.6B vs $1.9B, roughly 1.4× CME Group). Booz Allen Hamilton Holding Corp runs the higher net margin — 7.6% vs 0.1%, a 7.6% gap on every dollar of revenue. On growth, CME Group posted the faster year-over-year revenue change (14.5% vs -10.2%). Over the past eight quarters, CME Group's revenue compounded faster (10.8% CAGR vs -2.8%).

Booz Allen Hamilton Holding Corporation is the parent of Booz Allen Hamilton Inc., an American company specializing in digital transformation and artificial intelligence. The company is headquartered in McLean, Virginia, in the Washington metropolitan area, with 80 additional offices around the globe. Booz Allen's stated core business is to provide consulting, analysis, and engineering services to public- and private-sector organizations and nonprofits.

CME Group Inc. is an American financial services company based in Chicago, Illinois. It operates financial derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company owns 27% of S&P Dow Jones Indices. It is the world's largest operator of financial derivatives exchanges. Its exchanges are platforms for trading in agricultural products, currencies, energy, i...

BAH vs CME — Head-to-Head

Bigger by revenue
BAH
BAH
1.4× larger
BAH
$2.6B
$1.9B
CME
Growing faster (revenue YoY)
CME
CME
+24.7% gap
CME
14.5%
-10.2%
BAH
Higher net margin
BAH
BAH
7.6% more per $
BAH
7.6%
0.1%
CME
Faster 2-yr revenue CAGR
CME
CME
Annualised
CME
10.8%
-2.8%
BAH

Income Statement — Q3 FY2026 vs Q1 FY2026

Metric
BAH
BAH
CME
CME
Revenue
$2.6B
$1.9B
Net Profit
$200.0M
$1.2M
Gross Margin
51.9%
Operating Margin
8.8%
0.1%
Net Margin
7.6%
0.1%
Revenue YoY
-10.2%
14.5%
Net Profit YoY
7.0%
20.7%
EPS (diluted)
$1.63

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BAH
BAH
CME
CME
Q1 26
$1.9B
Q4 25
$2.6B
$1.6B
Q3 25
$2.9B
$1.5B
Q2 25
$2.9B
$1.7B
Q1 25
$3.0B
$1.6B
Q4 24
$2.9B
$1.5B
Q3 24
$3.1B
$1.6B
Q2 24
$2.9B
$1.5B
Net Profit
BAH
BAH
CME
CME
Q1 26
$1.2M
Q4 25
$200.0M
$1.2B
Q3 25
$175.0M
$908.0M
Q2 25
$271.0M
$1.0B
Q1 25
$192.7M
$956.2M
Q4 24
$186.9M
$874.6M
Q3 24
$390.1M
$912.8M
Q2 24
$165.2M
$883.2M
Gross Margin
BAH
BAH
CME
CME
Q1 26
Q4 25
51.9%
Q3 25
53.6%
Q2 25
51.3%
Q1 25
53.6%
Q4 24
55.2%
Q3 24
56.7%
Q2 24
53.4%
Operating Margin
BAH
BAH
CME
CME
Q1 26
0.1%
Q4 25
8.8%
61.8%
Q3 25
9.8%
63.3%
Q2 25
8.8%
66.7%
Q1 25
9.2%
67.5%
Q4 24
10.0%
62.1%
Q3 24
17.4%
64.6%
Q2 24
8.7%
65.3%
Net Margin
BAH
BAH
CME
CME
Q1 26
0.1%
Q4 25
7.6%
71.7%
Q3 25
6.1%
59.1%
Q2 25
9.3%
60.6%
Q1 25
6.5%
58.2%
Q4 24
6.4%
57.3%
Q3 24
12.4%
57.6%
Q2 24
5.6%
57.6%
EPS (diluted)
BAH
BAH
CME
CME
Q1 26
Q4 25
$1.63
$3.24
Q3 25
$1.42
$2.49
Q2 25
$2.16
$2.81
Q1 25
$1.52
$2.62
Q4 24
$1.45
$2.40
Q3 24
$3.01
$2.50
Q2 24
$1.27
$2.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BAH
BAH
CME
CME
Cash + ST InvestmentsLiquidity on hand
$882.0M
$2.4B
Total DebtLower is stronger
$3.9B
$3.4B
Stockholders' EquityBook value
$1.0B
Total Assets
$7.1B
$202.0B
Debt / EquityLower = less leverage
3.84×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BAH
BAH
CME
CME
Q1 26
$2.4B
Q4 25
$882.0M
$4.5B
Q3 25
$816.0M
$2.6B
Q2 25
$711.0M
$2.1B
Q1 25
$885.0M
$1.5B
Q4 24
$453.5M
$3.0B
Q3 24
$558.7M
$2.4B
Q2 24
$297.7M
$1.9B
Total Debt
BAH
BAH
CME
CME
Q1 26
$3.4B
Q4 25
$3.9B
Q3 25
$4.0B
Q2 25
$4.0B
Q1 25
$4.0B
Q4 24
$3.4B
Q3 24
$3.4B
Q2 24
$3.4B
Stockholders' Equity
BAH
BAH
CME
CME
Q1 26
Q4 25
$1.0B
$28.7B
Q3 25
$996.0M
$28.2B
Q2 25
$1.1B
$27.7B
Q1 25
$1.0B
$27.0B
Q4 24
$1.2B
$26.5B
Q3 24
$1.2B
$28.2B
Q2 24
$1.1B
$27.6B
Total Assets
BAH
BAH
CME
CME
Q1 26
$202.0B
Q4 25
$7.1B
$198.4B
Q3 25
$7.2B
$187.1B
Q2 25
$7.2B
$179.9B
Q1 25
$7.3B
$157.8B
Q4 24
$6.8B
$137.4B
Q3 24
$6.9B
$137.8B
Q2 24
$6.6B
$123.4B
Debt / Equity
BAH
BAH
CME
CME
Q1 26
Q4 25
3.84×
Q3 25
3.98×
Q2 25
3.74×
Q1 25
3.99×
Q4 24
2.79×
Q3 24
2.83×
Q2 24
3.14×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BAH
BAH
CME
CME
Operating Cash FlowLast quarter
$261.0M
Free Cash FlowOCF − Capex
$248.0M
FCF MarginFCF / Revenue
9.5%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
1.30×
TTM Free Cash FlowTrailing 4 quarters
$933.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BAH
BAH
CME
CME
Q1 26
Q4 25
$261.0M
$1.1B
Q3 25
$421.0M
$968.1M
Q2 25
$119.0M
$1.1B
Q1 25
$219.0M
$1.1B
Q4 24
$150.8M
$1.0B
Q3 24
$587.1M
$1.0B
Q2 24
$52.1M
$776.9M
Free Cash Flow
BAH
BAH
CME
CME
Q1 26
Q4 25
$248.0M
$1.1B
Q3 25
$395.0M
$949.7M
Q2 25
$96.0M
$1.0B
Q1 25
$194.4M
$1.1B
Q4 24
$133.6M
$991.7M
Q3 24
$563.3M
$973.2M
Q2 24
$19.7M
$758.7M
FCF Margin
BAH
BAH
CME
CME
Q1 26
Q4 25
9.5%
66.8%
Q3 25
13.7%
61.8%
Q2 25
3.3%
61.5%
Q1 25
6.5%
67.1%
Q4 24
4.6%
65.0%
Q3 24
17.9%
61.4%
Q2 24
0.7%
49.5%
Capex Intensity
BAH
BAH
CME
CME
Q1 26
Q4 25
0.5%
2.0%
Q3 25
0.9%
1.2%
Q2 25
0.8%
1.1%
Q1 25
0.8%
0.9%
Q4 24
0.6%
1.7%
Q3 24
0.8%
1.9%
Q2 24
1.1%
1.2%
Cash Conversion
BAH
BAH
CME
CME
Q1 26
Q4 25
1.30×
0.96×
Q3 25
2.41×
1.07×
Q2 25
0.44×
1.03×
Q1 25
1.14×
1.17×
Q4 24
0.81×
1.16×
Q3 24
1.50×
1.10×
Q2 24
0.32×
0.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BAH
BAH

Defense Clients$1.5B55%
Civil Clients$732.0M28%
Intelligence Clients$434.0M17%

CME
CME

Segment breakdown not available.

Related Comparisons